🇺🇸 FDA
Patent

US 6838081

Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient

expired A61KA61K2039/55522A61K38/193

Quick answer

US patent 6838081 (Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient) held by The Regents of the University of California expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/55522, A61K38/193, A61K38/2026